Tong Chen
Huashan Hospital
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Tong Chen as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-11 23:47 UTC. Open this list on ClinicalTrials.gov
- Ph2/Ph3NCT07185373 · Orelabrutinib Combined With Teniposide, Rituximab and Methotrexate for Newly Diagnosed PCNSLHuashan Hospital · recruiting · Primary Central Nervous System Lymphoma · principal investigator
- N/ANCT06115824 · New-diagnosed PCNSL Treated With Methotrexate (MTX) and Orelabrutinib-based RegimenHuashan Hospital · completed · Primary Central Nervous System Lymphoma · principal investigator
- Ph1/Ph2NCT05698147 · Selinexor in Combination With MTX+Ritu to Treat R/R CNSLTong Chen, MD · recruiting · Central Nervous System Lymphoma · principal investigator
- Ph1NCT05036577 · A Dose-escalating Pilot Study of Orelabrutinib for Newly-diagnosed PCNSLHuashan Hospital · completed · Primary Central Nervous System Lymphoma · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-11 23:47 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. 3 other NIH projects list an investigator with the same name at a different institution and are left out. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-11 23:47 UTC. The ranking covers the 200 most relevant of 940 PubMed records, and a shared surname and initials can bring in a namesake. All 940 on PubMed
- Ipilimumab plus dacarbazine for previously untreated metastatic melanoma.N Engl J Med · 20113,578 citationsRCR 87.2
- Two Randomized Phase 3 Studies of Aducanumab in Early Alzheimer's Disease.J Prev Alzheimers Dis · 20221,195 citationsRCR 105.4
- 1,024 citationsRCR 35.1
- Swedish two-county trial: impact of mammographic screening on breast cancer mortality during 3 decades.Radiology · 2011538 citationsRCR 16.7
- Tazemetostat in advanced epithelioid sarcoma with loss of INI1/SMARCB1: an international, open-label, phase 2 basket study.Lancet Oncol · 2020363 citationsRCR 13.8
- Antifungal Combinations for Treatment of Cryptococcal Meningitis in Africa.N Engl J Med · 2018337 citationsRCR 17.6
- Single-Dose Liposomal Amphotericin B Treatment for Cryptococcal Meningitis.N Engl J Med · 2022245 citationsRCR 25.9
- Nivolumab plus Ipilimumab in Microsatellite-Instability-High Metastatic Colorectal Cancer.N Engl J Med · 2024242 citationsRCR 25.6
- Tiotropium in Early-Stage Chronic Obstructive Pulmonary Disease.N Engl J Med · 2017229 citationsRCR 10.0
- 214 citationsRCR 43.6